- 15-01-2020AVROBIO Announces Clinical and Regulatory Progress For Gaucher Disease Program
- 10-01-2020PR001 Administered to International Type 2 Gaucher Disease Patient Via Compassionate Use Pathway
- 08-01-2020Prevail Therapeutics Is Recruiting Patients For PROPEL, a Clinical Trial Testing An Investigational Gene Therapy Called PR001 to Treat Parkinson’s Disease In People with GBA Mutations
- 17-12-2019December 2019 Newsletter
LINK TO ONE OF OUR 55 MEMBER ASSOCIATIONS FOR LOCAL SUPPORT, ADVICE AND NEWS
view map
close- Finland
- Norway
- Sweden
- Estonia
- Russian Federation
- Latvia
- Denmark
- Lithuania
- United Kingdom
- Netherlands
- Ireland
- Poland
- Germany
- Belgium
- Czech Republic
- Ukraine
- Slovakia
- Luxembourg
- Moldova, Republic of
- Austria
- France
- Switzerland
- Romania
- Slovenia
- Croatia
- Serbia
- Bosnia & Herzegovina
- Bulgaria
- Italy
- Macedonia, the Former Yugoslav Republic of
- Spain
- Greece
- Israel
IGA Downloads
The IGA is happy to publish the following documents for those wishing to learn more about the IGA and its work.
Please feel free to download them from this page
- IGA's Strategic Plan
- IGA Best Practice leaflet 2018
- IGA Best Practice Poster 2018
- IGA Articles of Association
- IGA Certificate of Registration
- IGA Code of Practice on Relationships with the Pharmaceutical Industry
- Addendum to IGA Code of Practice on Relationships with the Pharmaceutical Industry - Glossary
- IGA volunteer charter
- EGA Posters
- EGA Scientific Paper 2014: a survey of member patient organisations’ activities, healthcare environments and concerns
